Cohera Medical, a provider of wound care products and surgical adhesives, announced today that it has snagged $16.1 million in a second round of financing led by Bradford Capital Partners. Kern Whelan
and several previous investors also participated. The new money will be used to further develop the Pittsburgh company’s TissuGlu product, a sprayable adhesive tailored to plastic surgery needs, as well as several other products in the pipeline.

With tummy tucks the prime target, Cohera hopes to launch clinical trials of TissuGlu in Germany by the second quarter of next year, reports VentureWire. It is also working on adhesives appropriate for hernia surgery and bone surgery wounds.

Prior to this round, the company raised $6.8 million in August 2006, most of it coming from Kern Whelan.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.